Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiki Masuishi

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 26, 2016
[Current Progress and Feasibility of Using Molecular-Targeted Agent Combinations for Metastatic Colorectal Cancer]Toshiki Masuishi, Kei Muro
Journal of Gastrointestinal Oncology|September 12, 2022
A post-marketing safety study of ramucirumab with FOLFIRI in patients with metastatic colorectal cancerToshiki Masuishi, Soshi Nagaoka, Long Jin, et al.
Drugs - Real World Outcomes|April 27, 2023
Post-Marketing Safety Study of Ramucirumab Plus FOLFIRI: Analysis of Age and Initial Dose of Irinotecan in Patients with Metastatic Colorectal CancerToshiki Masuishi, Soshi Nagaoka, Long Jin, et al.
Case Reports in Oncology|May 25, 2019
Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard TherapiesSeiichiro Mitani, Shigenori Kadowaki, Kyoko Kato, et al.
BMC Infectious Diseases|June 7, 2022
Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patientNaoya Itoh, Nana Akazawa, Yuichi Ishibana, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 19, 2012
[A case of advanced gastric cancer with multiple liver metastases that achieved long-term survival on monotherapy of S-1]Toshiki Masuishi, Yoshinori Sakai, Tomoko Soma, et al.
International Journal of Clinical Oncology|October 16, 2020
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective studyHiroyuki Arai, Masahiro Kawahira, Hirofumi Yasui, et al.
The Oncologist|May 8, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
The Oncologist|April 17, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
Future Oncology (London, England)|May 30, 2020
WJOG10517G: a multicenter Phase II study of mFOLFOX6 in gastric cancer patients with severe peritoneal metastasesToshiki Masuishi, Takako Eguchi Nakajima, Kentaro Yamazaki, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 26, 2016
[Current Progress and Feasibility of Using Molecular-Targeted Agent Combinations for Metastatic Colorectal Cancer]Toshiki Masuishi, Kei Muro
Journal of Gastrointestinal Oncology|September 12, 2022
A post-marketing safety study of ramucirumab with FOLFIRI in patients with metastatic colorectal cancerToshiki Masuishi, Soshi Nagaoka, Long Jin, et al.
Drugs - Real World Outcomes|April 27, 2023
Post-Marketing Safety Study of Ramucirumab Plus FOLFIRI: Analysis of Age and Initial Dose of Irinotecan in Patients with Metastatic Colorectal CancerToshiki Masuishi, Soshi Nagaoka, Long Jin, et al.
Case Reports in Oncology|May 25, 2019
Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard TherapiesSeiichiro Mitani, Shigenori Kadowaki, Kyoko Kato, et al.
BMC Infectious Diseases|June 7, 2022
Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patientNaoya Itoh, Nana Akazawa, Yuichi Ishibana, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 19, 2012
[A case of advanced gastric cancer with multiple liver metastases that achieved long-term survival on monotherapy of S-1]Toshiki Masuishi, Yoshinori Sakai, Tomoko Soma, et al.
International Journal of Clinical Oncology|October 16, 2020
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective studyHiroyuki Arai, Masahiro Kawahira, Hirofumi Yasui, et al.
The Oncologist|May 8, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
The Oncologist|April 17, 2026
Predictive factors for early mortality after regorafenib or trifluridine/tipiracil initiation in metastatic colorectal cancerToshiki Masuishi, Shota Fukuoka, Atsuo Takashima, et al.
Future Oncology (London, England)|May 30, 2020
WJOG10517G: a multicenter Phase II study of mFOLFOX6 in gastric cancer patients with severe peritoneal metastasesToshiki Masuishi, Takako Eguchi Nakajima, Kentaro Yamazaki, et al.
Pageof 12